Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Mereo BioPharma Group plc

MREO•NASDAQ
Healthcare
Biotechnology
$0.39
$-0.00(-0.23%)
U.S. Market opens in 25h 41m

Mereo BioPharma Group plc (MREO) Stock Overview

Explore Mereo BioPharma Group plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap61.6M
P/E Ratio-1.48
EPS (TTM)$-0.25
ROE-0.75%
Fundamental Analysis

AI Price Forecasts

1 Month$0.06
3 Months$0.71
1 Year Target$0.00

MREO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mereo BioPharma Group plc (MREO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 37.70, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.48 and a market capitalization of 61.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.23%
5-Day Change
-1.03%
1-Month Change
3.79%
3-Month Change
-82.21%
6-Month Change
-79.14%
Year-to-Date (YTD) Change
-24.37%
1-Year Change
-84.56%
3-Year Change
-55.32%
5-Year Change
-90.68%
All-Time (Max) Change
-94.06%

Contact Information

https://www.mereobiopharma.com
44 33 3023 7300
One Cavendish Place, London, NaN, W1G 0QF

Company Facts

360 Employees
IPO DateApr 24, 2019
CountryGB
Actively Trading

Frequently Asked Questions